Bone Health Complex.

Bone mineral is largely hydroxyapatite, a calcium phosphate lattice laid down on a collagen scaffold. A bone-directed complex supplies calcium as the bulk mineral that the other components help absorb, direct or incorporate. Absorption is dose-dependent and falls as a single dose rises, which is why split dosing is common formulation practice.

Calcitriol, the active hormone made from cholecalciferol, drives transcription of the intestinal calcium transport machinery including calbindin and the TRPV6 channel. Without adequate vitamin D status, active transcellular calcium uptake falls and absorption relies on the passive paracellular route. This is why calcium and vitamin D3 travel together in nearly every bone formulation.

Vitamin K is the cofactor for gamma-glutamyl carboxylase, the enzyme that carboxylates osteocalcin and matrix Gla protein so they can bind calcium ions. Uncarboxylated osteocalcin in serum falls when vitamin K intake rises, which is a marker of vitamin K sufficiency rather than an outcome in itself. MK-7 has a longer circulating half-life than MK-4, which shapes dosing intervals.

The hepatic 25-hydroxylase and renal 1-alpha-hydroxylase steps that activate vitamin D are magnesium-dependent, as is the vitamin D binding protein interaction. Magnesium also sits on the hydroxyapatite crystal surface and influences crystal size. Large single doses of calcium and magnesium share divalent cation absorption routes, so very high calcium can blunt magnesium uptake in the same dose.

Boron supplementation has been reported to reduce urinary calcium and magnesium loss in controlled feeding work and to shift steroid hormone and vitamin D metabolite levels. These are biochemical markers, not bone outcomes. Boron appears in bone blends at low microgram to milligram amounts on that basis.

Alkaline phosphatase, the osteoblast enzyme that liberates inorganic phosphate for mineral deposition, is a zinc metalloenzyme. Zinc is also required by collagen-processing enzymes that prepare the organic matrix. High calcium taken in the same dose can lower zinc absorption, so the two are often separated across the day.

Lysyl oxidase cross-links collagen and elastin fibres, and it needs copper at its active site. Without cross-linking the bone matrix is laid down but mechanically weaker. Sustained high zinc intake induces intestinal metallothionein and lowers copper absorption, which is why bone blends carrying zinc usually carry a small amount of copper alongside it.

Glycosyltransferases that assemble the glycosaminoglycan chains of bone and cartilage proteoglycan require manganese. Manganese superoxide dismutase in mitochondria depends on it too. Manganese shares divalent cation transport with iron, so iron status influences how much manganese is taken up.

Orthosilicic acid has been linked in animal work to collagen type I synthesis and early mineralisation, and dietary silicon intake correlates with bone mineral density in cohort analyses. Those cohort findings are associations and do not establish cause. Bone blends usually supply it as a stabilised orthosilicic acid or a bamboo or horsetail extract.

Hydroxyapatite carries more calcium than phosphate on a molar basis, so both minerals are needed for deposition. Ordinary diets rarely lack phosphorus, and some calcium salts such as dicalcium phosphate supply both at once. Very high calcium doses bind phosphate in the gut lumen and lower its absorption, which matters more in a low-phosphorus diet.

Type I collagen is roughly a third of bone by weight and forms the template on which mineral crystallises. Hydrolysed collagen supplies glycine, proline and hydroxyproline-containing di- and tripeptides that appear in blood after ingestion. Trials in postmenopausal women have reported changes in bone turnover markers, which are markers rather than fracture outcomes.

Ascorbate keeps the iron centre of prolyl and lysyl hydroxylase reduced so procollagen can be hydroxylated and form a stable triple helix. Undermodified collagen is degraded rather than secreted. This makes vitamin C a direct input to the organic phase of bone as well as to skin and tendon.

Calcium taken in the same dose as iron reduces iron absorption, an interaction seen with both haem and non-haem iron. Iron and manganese also share the DMT1 transporter. The usual formulation answer is to place a calcium-heavy bone product and an iron product at different times of day.

Retinoic acid signalling and vitamin D signalling both run through RXR heterodimers, and high preformed retinol intake has been associated in cohort data with lower bone mineral density. That is an association from observational work, not a demonstrated cause. Bone formulations often supply vitamin A mainly as beta-carotene for this reason.

Fermentation of inulin-type fructans in the colon lowers luminal pH and raises the pool of soluble calcium available for passive uptake. Isotope studies in adolescents have measured higher fractional calcium absorption with prebiotic fructans. The effect is measured on absorption, which is a marker step rather than a bone outcome.

Sodium and calcium share reabsorption handling in the proximal tubule, so a higher sodium load raises urinary calcium loss. Each additional gram of sodium excreted carries a measurable amount of calcium with it. This is why sodium intake is part of the picture whenever calcium balance is discussed.

Caffeine produces a small, short-lived rise in urinary calcium and a modest fall in intestinal calcium absorption efficiency. The size of the effect is small relative to total intake and is generally offset when calcium intake is adequate. It matters most at low calcium intake.

Phytate in whole grains and legumes binds calcium, zinc and iron in the gut and carries them past absorption. Phytase hydrolyses the inositol phosphate ester bonds and releases those cations into solution. In a plant-heavy diet this is a meaningful determinant of how much of a mineral dose is actually taken up.

Galloyl groups on tannins chelate iron, calcium and zinc into poorly soluble complexes in the gut lumen. Strong tea and coffee taken with a mineral dose lower the fraction absorbed. Spacing the mineral dose from tannin-rich drinks is the ordinary workaround.

Strontium is chemically similar to calcium, is absorbed by the same routes and deposits into the hydroxyapatite lattice in place of calcium. Because it shares those routes, strontium and calcium taken together reduce each other's uptake. Its higher atomic number also inflates DXA density readings, so a measured density change after strontium intake is partly an artefact of the measurement.

Alkaline potassium salts such as potassium citrate and bicarbonate reduce net acid load and lower urinary calcium excretion in metabolic balance studies. The measured endpoint is calcium in urine, a marker of balance rather than a bone outcome. Fruit and vegetable intake is the usual dietary source of the same effect.